229 results
10-K405
1998 FY
EX-10.19
ATRX
Adhera Therapeutics, Inc.
30 Mar 99
Annual report (delinquent filer disclosure)
12:00am
the date when price and reimbursement
approvals for the Product had been obtained in all countries in the
Territory but before … the expiration of a period of three (3) years
from the date when price and reimbursement approvals for the Product
had been obtained
8-K
ATRX
Adhera Therapeutics, Inc.
14 Jul 09
MDRNA Appoints New Chief Financial Officer
12:00am
(determined on a pro-rated basis as to the year in which the termination occurs), pay for accrued but unused paid time off, and reimbursement … . Garcia shall be entitled to receive salary, pay for accrued but unused paid time off, and reimbursement of expenses through the termination date, (ii
8-K
EX-10.1
ATRX
Adhera Therapeutics, Inc.
19 Sep 14
Marina Biotech Announces the Election of Donald A. Williams to its Board of Directors
12:00am
for accrued but unused paid time off (the “Vacation Payment”), and reimbursement for expenses (the “Reimbursement Payment”) pursuant to Section 13 hereof … Salary Payment, the Vacation Payment, and the Reimbursement Payment to Executive within thirty (30) days after the date of such termination. The Company
8-K
ATRX
Adhera Therapeutics, Inc.
13 Jun 08
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
12:00am
) pay for accrued but unused vacation time, and (iv) reimbursement for expenses through the date of termination, plus the lesser of (a) the balance … for the remainder of their respective terms. Dr. Quay will also receive salary, pay for accrued but unused vacation time, and reimbursement of expenses
8-K
ATRX
Adhera Therapeutics, Inc.
19 Sep 14
Marina Biotech Announces the Election of Donald A. Williams to its Board of Directors
12:00am
occurs, (iii) pay for accrued but unused paid time off, and (iv) reimbursement for expenses through the date of termination, plus an amount equal to 12 … salary, pay for accrued but unused paid time off, and reimbursement of expenses through the date of termination.
If Mr. French’s employment
8-K
EX-10.2
subx mkr90bvty
5 Apr 19
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
9:29am
8-K
EX-10.3
qoa96 hpp
8 Sep 11
Marina Biotech Announces Organizational Changes
12:00am
8-K
EX-99.1
e07cl sncnekl
7 May 07
Nastech Announces First Quarter 2007 Financial Results
12:00am
8-K
el1zgb7hm8uiyu
8 Sep 11
Marina Biotech Announces Organizational Changes
12:00am
8-K
4dsi3z9 p4n
1 Nov 06
Nastech Announces Third Quarter 2006 Financial Results
12:00am
424B5
ik5sjl x27p5j
14 Jan 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
sapic
15 Mar 06
Nastech Announces Fourth Quarter and Full Year 2005 Financial Results
12:00am
8-K
EX-99.1
pq6p512w izs9
3 May 06
Nastech Announces First Quarter 2006 Financial Results
12:00am
8-K
EX-10.1
odj1 xujoib2ab
8 Sep 11
Marina Biotech Announces Organizational Changes
12:00am
8-K
EX-10.1
uwq1mzpk942fhfdnx oy
14 Jul 09
MDRNA Appoints New Chief Financial Officer
12:00am
8-K
EX-10.1
wgnxjhhz6fy945ksam
30 Oct 08
MDRNA, Inc. Appoints Barry Polisky, Ph.D., as Chief Scientific Officer
12:00am
424B5
hgtdey7lnsk61
24 Dec 09
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
je9q 60hcta
4 Aug 08
MDRNA, Inc. Announces Second Quarter 2008 Financial Results and Additional Corporate Restructuring
12:00am